News Updates
More Articles
- Solving the Challenge of Limited Data: Bayesian Statistics to the Rescue in Rare Disease Drug Development
- The Female Data Deficit: How Drug Development Still Fails Women
- China’s Out-Licensing Deals Bear Fruit in 2025
- From Paper to Digital: The Evolution of Electronic Product Information and the LatAm Playbook Experience
- The Hidden Governance Gap in Modern Clinical Trials
From Cells to Animals and Back Again: The Shifting Landscape of Cancer Efficacy and Safety Models
This article explores how cancer testing has evolved from early animal models to today’s advanced in vitro and computational methods, and why understanding the whole organism remains essential for developing effective therapies.
